Author
University of KentuckyORCID 0000-0002-7147-3978Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Enzo LaMontia-Hankin, Clayton J. Wollner, E. Taylor Stone…·Justin M. Richner
The paper develops mRNA-LNP vaccines encoding optimized prM/ENV proteins for all four DENV serotypes that induce protective immunity and reduce antibody-dependent enhancement.
Michael W. Crawford, Walid Abdelwahab, Karthik Siram…·Alec J. Hirsch
This paper develops a Powassan virus-like-particle (POW-VLP) vaccine adjuvanted with INI-4001, showing it enhances immunogenicity, reduces viral burden, and provides full protection in mice.
Elizabeth Geerling, E. Taylor Stone, Danielle H. Carpenter…·Amelia K. Pinto
This study shows that metabolic syndrome worsens SARS-CoV-2 disease and lowers vaccine effectiveness in mice.
Victoria Gnazzo, Hanaa Saleh, Ítalo A. Castro…·Carolina B. López
This paper tests DDO268 as an adjuvant for an influenza A virus nucleoprotein mRNA vaccine in mice, showing enhanced immune responses and protection against viral challenge.
Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden…·Mehul S. Suthar
This study shows that CD4+ and CD8+ T cells are necessary to prevent SARS-CoV-2 persistence in the nasal compartment but not in the lungs.